https://www.marketscreener.com/quote/stock/IRLAB-THERAPEUTICS-AB-61747292/news/IRLAB-s-Pioneering-Phase-IIb-Study-Withpirepemat-React-PD-Provides-New-Insights-in-Specific-Park-45889951/?utm_source=telegram&utm_medium=social&utm_campaign=share